You are leaving Medscape Education
Cancel Continue
Log in to save activities Your saved activities will show here so that you can easily access them whenever you're ready. Log in here CME & Education Log in to keep track of your credits.
 

CPD

Exploring Key Progress With Targeted Therapies for Urothelial Carcinoma: A Quickfire Expert Exchange

  • Authors: Thomas Powles, MBBS, MRCP, MD; Cora N. Sternberg, MD
  • CPD Released: 3/24/2022
  • Valid for credit through: 3/24/2023
Start Activity

  • Credits Available

    Non-US Physicians - maximum of 0.25 CPD

    You Are Eligible For

    • Letter of Completion

Target Audience and Goal Statement

This educational activity is intended for an international audience of non-US hematology and oncology specialists, urologists, and pathologists.

The goal of this activity is to provide an informative snapshot of where we are to date with targeted therapies for advanced/metastatic urothelial carcinoma from a clinical perspective.

Upon completion of this activity, participants will:

  • Have increased knowledge regarding the
    • Available evidence for targeted therapies for locally advanced/metastatic urothelial carcinoma 
  • Demonstrate greater confidence in their ability to
    • Identify which patients with locally advanced/metastatic urothelial carcinoma could benefit from treatment with targeted therapies 


Disclosures

WebMD Global requires every individual in a position to control educational content to disclose all financial relationships with ineligible companies that have occurred within the past 24 months. Ineligible companies are organizations whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.

All relevant financial relationships for anyone with the ability to control the content of this educational activity are listed below and have been mitigated. Others involved in the planning of this activity have no relevant financial relationships with ineligible companies.


Faculty

  • Thomas Powles, MBBS, MRCP, MD

    Professor of Genitourinary Oncology
    Barts Cancer Institute
    Queen Mary University of London
    London, United Kingdom

    Disclosures

    Disclosure: Thomas Powles, MBBS, MRCP, MD, has the following relevant financial relationships:
    Advisor or consultant for: Astellas; AstraZeneca; Bristol Myers Squibb; Eisai; Exelixis; Incyte; Ipsen; Johnson & Johnson; Merck; Merck Serono; Merck Sharpe & Dohme; Novartis; Pfizer; Roche; Seagen Inc., formerly Seattle Genetics, Inc.
    Grants for clinical research from: Astellas; AstraZeneca; Bristol Myers Squibb; Eisai; Exelixis; Ipsen; Johnson & Johnson; Merck; Merck Sharpe & Dohme; Merck Serono; Novartis; Pfizer; Roche; Seagen Inc., formerly Seattle Genetics, Inc.
    Other: Travel: AstraZeneca; Ipsen; Merck Sharpe & Dohme; Pfizer; Roche

  • Cora N. Sternberg, MD

    Clinical Director
    Englander Institute for Precision Medicine
    Professor of Medicine
    Sandra and Edward Meyer Cancer Center
    Weill Cornell Medicine
    New York-Presbyterian
    New York, New York, USA

    Disclosures

    Disclosure: Cora N. Sternberg, MD, has the following relevant financial relationships:
    Advisor or consultant for: Astellas; AstraZeneca; Bayer; Bristol Myers Squibb; Foundation Medicine; Gilead; Immunomedics; Incyte; Janssen; Merck; Merck Sharpe & Dohme; Pfizer; Roche-Genentech; Sanofi-Genzyme

Editor

  • Megan Cannon, PhD

    Medical Education Director, WebMD Global, LLC

    Disclosures

    Disclosure: Megan Cannon, PhD, has disclosed no relevant financial relationships.

Compliance Reviewer

  • Stephanie Corder, ND, RN, CHCP

    Associate Director, Accreditation and Compliance

    Disclosures

    Disclosure: Stephanie Corder, ND, RN, CHCP, has no relevant financial relationships.

Peer Reviewer

This activity has been peer reviewed and the reviewer has disclosed no relevant financial relationships.


Accreditation Statements

    For Physicians

  • The Faculty of Pharmaceutical Medicine of the Royal Colleges of Physicians of the United Kingdom (FPM) has reviewed and approved the content of this educational activity and allocated it 0.25 continuing professional development credits (CPD).

    Contact WebMD Global

For questions regarding the content of this activity, contact the accredited provider for this CME/CE activity noted above. For technical assistance, contact [email protected]


Instructions for Participation and Credit

There are no fees for participating in or receiving credit for this online educational activity. For information about your eligibility to claim credit, please consult your professional licensing board.

This activity is designed to be completed within the time designated on the title page; physicians should claim only those credits that reflect the time actually spent participating in the activity. To successfully earn credit, participants must complete the activity online during the credit eligibility period that is noted on the title page.

Follow these steps to claim a credit certificate for completing this activity:

  1. Read the information provided on the title page regarding the target audience, learning objectives, and author disclosures, read and study the activity content and then complete the post-test questions. If you earn a passing score on the post-test and we have determined based on your registration profile that you may be eligible to claim CPD credit for completing this activity, we will issue you a CPD credit certificate.
  2. Once your CPD credit certificate has been issued, you may view and print the certificate from your CME/CE Tracker. CPD credits will be tallied in your CME/CE Tracker and archived for 6 years; at any point within this time period you can print out the tally as well as the certificates by accessing "Edit Your Profile" at the top of the Medscape Education homepage.

We encourage you to complete an Activity Evaluation to provide feedback for future programming.

You may now view or print the certificate from your CME/CE Tracker. You may print the certificate but you cannot alter it. Credits will be tallied in your CME/CE Tracker and archived for 6 years; at any point within this time period you can print out the tally as well as the certificates by accessing "Edit Your Profile" at the top of your Medscape homepage.

*The credit that you receive is based on your user profile.

CPD

Exploring Key Progress With Targeted Therapies for Urothelial Carcinoma: A Quickfire Expert Exchange

Authors: Thomas Powles, MBBS, MRCP, MD; Cora N. Sternberg, MDFaculty and Disclosures

CPD Released: 3/24/2022

Valid for credit through: 3/24/2023

processing....

A Powerpoint version of the slides from this presentation
is available for use as a professional resource from Medscape Education.

  • Print